Brief: Amicus Therapeutics Announces Q1 2023 Financial Results And Corporate Updates

Amicus Therapeutics

10/05/2023 13:26

May 10 (Reuters) - Amicus Therapeutics Inc  FOLD.O :
    * AMICUS THERAPEUTICS ANNOUNCES FIRST QUARTER 2023 FINANCIAL
RESULTS AND CORPORATE UPDATES
    * AMICUS THERAPEUTICS INC - ON TRACK TO DELIVER FULL-YEAR
2023
GALAFOLD REVENUE GROWTH OF 12%-17% AT CER
    * AMICUS THERAPEUTICS INC - U.S. FDA PRE-APPROVAL INSPECTION
FOR
AT-GAA COMPLETE; APPROVAL EXPECTED 3Q 2023
    * AMICUS THERAPEUTICS INC - EUROPEAN LAUNCH OF
POMBILITI(®)+OPFOLDA(®) EXPECTED 3Q 2023
    * AMICUS THERAPEUTICS INC - NON-GAAP PROFITABILITY PROJECTED
IN 2H
2023
    * AMICUS THERAPEUTICS INC - NON-GAAP OPERATING EXPENSE
GUIDANCE
FOR FY 2023 IS $340 MILLION TO $360 MILLION
    * AMICUS THERAPEUTICS INC- QTRLY LOSS PER SHARE $0.18

Source text for Eikon:  ID:nGNXF4bRD 
Further company coverage:  FOLD.O 

 ((Reuters.Briefs@thomsonreuters.com;))